Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants

Sponsor
University of Sao Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT03352154
Collaborator
Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (Other)
21
1
42.4

Study Details

Study Description

Brief Summary

Bilateral severe to profound hearing loss is a socially disabling handicap. Cochlear implants can be used to improve hearing in cases where conventional hearing aids are not effective. There are few studies about the long latency Auditory Evoked Potential (P300), in individuals with hearing loss and Cochlear Implant (CI) users. The aim of this project is to study the behavior of P300 in users of unilateral CI.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: P300 - Auditory long latency potential
N/A

Detailed Description

Bilateral severe to profound hearing loss is a socially disabling handicap. Cochlear implants can be used to improve hearing in cases where conventional hearing aids are not effective. There are few studies about the long latency Auditory Evoked Potential (P300), in individuals with hearing loss and Cochlear Implant (CI) users. The aim of this project is to study the behavior of P300 in users of unilateral CI. Twenty patients with bilateral severe and/or profound post-lingual deafness, all submitted to CI surgery, will be evaluated. Patients will be evaluated through P300 testing on the day before CI surgery, on the day of device activation and 6 months after device use. It is hoped that this study can contribute to the understanding of the mechanisms of brain plasticity involved in the recovery of hearing function after CI surgery. There are few studies on the behavior of P300 in CI users and there are no studies showing how central stimulation occurs after device implantation, during the phases of pre CI, CI activation and 6 months after CI.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
21 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Verify the alteration of the latency and amplitude of the P300 as markers of the cognitive response after Cochlear Implant Assist in prognosis after implantation cochlear implant.Verify the alteration of the latency and amplitude of the P300 as markers of the cognitive response after Cochlear Implant Assist in prognosis after implantation cochlear implant.
Masking:
None (Open Label)
Masking Description:
Not Apply
Primary Purpose:
Diagnostic
Official Title:
Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants
Actual Study Start Date :
Nov 20, 2016
Anticipated Primary Completion Date :
Jun 4, 2020
Anticipated Study Completion Date :
Jun 4, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: patients with unilateral cochlear implants submitted to P300

Patients with unilateral cochlear implants, using the speech processor at least 6 months, submitted to P300 exam before CI surgery, on speech processor activation and after 06 months.

Diagnostic Test: P300 - Auditory long latency potential
Perform the P300 exams.

Outcome Measures

Primary Outcome Measures

  1. Improvement of the P300 Responses after CI [06 months after CI]

    Improving the cognitive process on CI receivers

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with post-lingual hearing loss undergoing cochlear implant surgery
Exclusion Criteria:
  • Prelingual hearing loss

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Sao Paulo
  • Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Investigators

  • Study Chair: Miguel Hyppolito, MD/PhD, Coordinator Health Auditory Care Program of the HCRP-FMRP-USP

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Miguel Angelo Hyppolito, Head of Otolaryngology, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT03352154
Other Study ID Numbers:
  • 38224814.2.0000.5440
First Posted:
Nov 24, 2017
Last Update Posted:
Mar 31, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Miguel Angelo Hyppolito, Head of Otolaryngology, University of Sao Paulo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2020